Literature DB >> 10457580

The value of somatosensory- and motor-evoked potentials in predicting and monitoring the effect of therapy in spondylotic cervical myelopathy. Prospective randomized study.

J Bednarík1, Z Kadanka, S Vohánka, L Stejskal, O Vlach, R Schröder.   

Abstract

STUDY
DESIGN: A 2-year follow-up prospective randomized electrophysiologic and clinical study of patients with spondylotic cervical myelopathy.
OBJECTIVE: To assess the value of somatosensory- and motor-evoked potentials in the evaluation and prediction of the effect of therapy. SUMMARY OF BACKGROUND DATA: Previous studies have yielded conflicting data concerning the correlation between the changes in evoked potential parameters and the clinical postsurgical outcome in spondylotic cervical myelopathy.
METHODS: Sixty-one patients with magnetic resonance images suggesting spondylotic cervical cord compression and clinical signs of cervical myelopathy were divided into two groups according to the degree of clinical cervical cord involvement. The 49 patients with mild and moderate spondylotic cervical myelopathy were randomized into groups that underwent either surgical or conservative therapy. Patients were evaluated clinically and by the means of somatosensory- and motor-evoked potentials.
RESULTS: The clinical and evoked potential changes showed good correlation on the group level, but poor correlation intraindividually. There were no significant evoked potential and clinical group changes after 6 months and 2 years in the mild myelopathy group treated either surgically and conservatively, whereas patients with severe myelopathy displayed significant improvement in clinical and evoked potential parameters after surgery. In a subgroup of patients, the isolated segmental medullar N13 abnormality could potentially predict favorable postsurgical clinical outcome.
CONCLUSIONS: Longitudinal evoked potentials showed limited use for evaluating the results of therapy in an individual patient. They could be useful in the group assessment of therapy results and in labeling a subgroup of patients with potentially favorable postsurgical outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10457580     DOI: 10.1097/00007632-199908010-00014

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  15 in total

Review 1.  The contribution of neurophysiology in the diagnosis and management of cervical spondylotic myelopathy: a review.

Authors:  R Nardone; Y Höller; F Brigo; V N Frey; P Lochner; S Leis; S Golaszewski; E Trinka
Journal:  Spinal Cord       Date:  2016-05-31       Impact factor: 2.772

Review 2.  [Diagnostics and conservative treatment of cervical and lumbar spinal stenosis].

Authors:  A Hug; S Hähnel; N Weidner
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

3.  Surgical Management of Cervical Spondylotic Myelopathy.

Authors:  Wesley Hsu; Michael J Dorsi; Timothy F Witham
Journal:  Neurosurg Q       Date:  2009-12-01

4.  Using Smartphones for Clinical Assessment in Cervical Spondylotic Myelopathy a Feasibility Study.

Authors:  Julien Francisco Zaldivar-Jolissaint; François Lechanoine; Bernard Krummenacher; Rivus Ferreira Arruda; Lukas Bobinski; Emmanuel de Schlichting; John Michael Duff
Journal:  J Med Device       Date:  2021-10-22       Impact factor: 0.582

Review 5.  [Cervical myelopathy as a complication of rheumatoid arthritis].

Authors:  A C Arlt; J Steinmetz
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

6.  The utility of somatosensory evoked potential monitoring during cervical spine surgery: how often does it prompt intervention and affect outcome?

Authors:  Michael S Roh; Tracy J Wilson-Holden; Anne M Padberg; Jong-Beom Park; K Daniel Riew
Journal:  Asian Spine J       Date:  2007-06-30

Review 7.  Surgery for cervical radiculopathy or myelopathy.

Authors:  Ioannis Nikolaidis; Ioannis P Fouyas; Peter Ag Sandercock; Patrick F Statham
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  One stage laminoplasty and posterior herniotomy for the treatment of myelopathy caused by cervical stenosis with cervical disc herniation.

Authors:  Bin Yue; Bohua Chen; Xue-Xiao Ma; Yong-Ming Xi; Hong-Fei Xiang; You-Gu Hu; Guoqing Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  The natural history and clinical syndromes of degenerative cervical spondylosis.

Authors:  John C Kelly; Patrick J Groarke; Joseph S Butler; Ashley R Poynton; John M O'Byrne
Journal:  Adv Orthop       Date:  2011-11-28

10.  Trial-to-trial latency variability of somatosensory evoked potentials as a prognostic indicator for surgical management of cervical spondylotic myelopathy.

Authors:  Hongyan Cui; Yazhou Wang; Xiang Li; Xiaobo Xie; Shengpu Xu; Yong Hu
Journal:  J Neuroeng Rehabil       Date:  2015-05-29       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.